Frontiers in immunology

Why flu vaccines often work poorly: vaccine protection methods, possible reasons, and suggestions to improve flu control

Updated

Abstract

Influenza vaccine effectiveness may remain below 45% due to antigenic mismatches and immunological factors.

  • Current vaccines primarily trigger antibodies against the viral hemagglutinin (HA) protein, blocking virus attachment.
  • Influenza vaccines require annual administration because of constant changes in circulating viruses and waning antibody levels.
  • Antigenic mismatches often result from HA evolution and production adaptations that alter key viral properties.
  • Repeated vaccinations can activate regulatory T cells, potentially diminishing antibody responses in both young and older adults.
  • Older adults may face additional challenges due to reduced capacity in memory T cells to activate HA-specific B cells.
  • Natural infections generate durable memory B cells, whereas traditional vaccinations do not consistently produce long-term immunity.

Simplified

Key numbers

10% to 60%
Vaccine Effectiveness Range
Fluctuations in adjusted influenza vaccine effectiveness since the 2004–05 season.
55.4% among children and 44.9% among adults
Annual Vaccination Coverage
Vaccination coverage in the US for the 2023–24 season.

Full Text

What this is

  • Influenza vaccines are less effective than other vaccines, often below 45%, due to and mismatches with circulating strains.
  • Annual vaccination is necessary but can lead to reduced immune responses over time, especially in older adults.
  • This review explores the immunological mechanisms of vaccine protection and suggests strategies for improving influenza control.

Essence

  • Current influenza vaccines show low effectiveness due to and repeated vaccinations, which can dampen immune responses. Strategies to enhance vaccine efficacy include using recombinant and mRNA technologies, improving strain selection, and developing better adjuvants.

Key takeaways

  • Influenza vaccine effectiveness fluctuates between 10% and 60%, with many seasons below 45%. This variability is primarily due to antigenic mismatches between the vaccine and circulating strains.
  • Repeated annual vaccination can lead to immune tolerance and reduced antibody responses, particularly in older adults. This phenomenon may diminish the protective effects of vaccination over time.
  • New vaccine strategies, including recombinant protein and mRNA vaccines, could improve effectiveness by better matching circulating strains and enhancing long-term immune memory.

Caveats

  • The review does not provide empirical data but discusses theoretical mechanisms and recommendations for improving vaccine effectiveness.
  • Current vaccine strategies may not adequately address the challenges posed by and the immunological consequences of repeated vaccinations.

Definitions

  • Antigenic drift: Gradual accumulation of mutations in viral antigens, making them less recognizable to the immune system.
  • Original antigenic sin: The phenomenon where the immune system preferentially recalls responses to the first strain encountered, limiting responses to new variants.

Simplified

Funding

Competing interests

Author RG was employed by Biologics Quality & Regulatory Consultant, LLC. Author KA was employed by TurboVax Inc. Author JC was employed by Cowell Vaccine Consulting. The author RG declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free